The burgeoning field of metabolic management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These novel therapies represent a significant https://macieghui033828.plpwiki.com/7282790/glp_3_receptor_agonists_retatrutide_trizepatide